tiprankstipranks
Trending News
More News >
BioLineRX Ltd. (IL:BLRX)
:BLRX
Israel Market

Bioline Rx (BLRX) Income Statement

Compare
2 Followers

Bioline Rx Income Statement

Last quarter (Q4 2024), Bioline Rx's total revenue was $11.75M, an increase of 144.77% from the same quarter last year. In Q4, Bioline Rx's net income was $-3.19M. See Bioline Rx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.94M$ 4.80M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 19.68M$ 1.11M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 40.09M$ 50.80M$ 29.16M$ 24.78M$ 22.93M
Depreciation and Amortization
$ 4.07M$ 1.38M$ 654.00K$ 703.00K$ 934.00K
EBITDA
$ 3.92M$ -57.09M$ -28.50M$ -24.07M$ -22.34M
Operating Income
$ -20.41M$ -49.69M$ -29.16M$ -24.78M$ -22.93M
Other Income/Expenses
$ 11.19M$ -10.92M$ 4.21M$ -2.28M$ -7.09M
Pretax Income
$ -9.22M$ -60.61M$ -24.95M$ -27.05M$ -30.02M
Net Income
$ -9.22M$ -60.61M$ -20.75M$ -28.14M$ -30.93M
Per Share Metrics
Basic EPS
$ -0.01$ -0.06$ -0.03$ -0.04$ -0.12
Diluted EPS
$ -0.01$ -0.06$ -0.03$ -0.04$ -0.12
Weighted Average Shares Outstanding
1.20B 963.37M 773.96M 662.93M 252.84M
Weighted Average Shares Outstanding (Diluted)
1.20B 963.37M 773.96M 662.93M 252.84M
Currency in USD

Bioline Rx Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis